Amri

iStock/macgyverhh

PE firms' plan to take AMRI private on track

By Staff reporter

The Carlyle Group and GTCR LLC are poised to complete the takeover of Albany Molecular Research (AMRI) after the early termination of the mandatory waiting period that covers such deals in the US.

Albany Molecular Research Inc. (AMRI) is a global contract research and manufacturing organization. (Image: iStock/macgyverhh)

AMRI set to be acquired by private equity

By Melissa Fassbender

Private equity continues to make inroads in the contract research industry with two firms set to purchase AMRI in a deal worth $21.75 per share.

AMRI will work with NCATS technicians (source NIH)

AMRI says it is well placed to win more NCATS contracts

AMRI gets 5-year NIH API manufacturing and process dev contract

By Gareth Macdonald

AMRI has been hired by the NIH to provide synthesis and manufacturing services for APIs being developed by the National Center for Advancing Translational Sciences (NCATS) division of preclinical innovation.

AMRI acquisitions driving up contract revenue in Q2

AMRI acquisitions driving up contract revenue in Q2

By Zachary Brennan

With contract revenue growth of nearly 40%, CDMO (contract development and manufacturing organization) AMRI is seeing its acquisitions of OsoBio, two Aptuit facilities and a UK aseptic facility pay off.

AMRI sets sights on acquiring Indian API manufacturer, CEO says

AMRI sets sights on acquiring Indian API manufacturer, CEO says

By Zachary Brennan

Following its three acquisitions over the last year, AMRI is now looking to extend its footprint into India further with the acquisition of a FDA-approved API site, William Marth, president and CEO of AMRI, told attendees at the Barclays Global Healthcare...

AMRI to acquire CDMO Cedarburg for $41M

AMRI to acquire CDMO Cedarburg for $41M

By Zachary Brennan

AMRI will acquire Cedarburg Pharmaceuticals for $38.2m (€27.7) in cash, plus $2.8m of assumed liabilities, to expand its API and drug development offerings.

Large Scale Manufacturing Drives AMRI Q1 Revenue Uptick

Large Scale Manufacturing Drives AMRI Q1 Revenue Uptick

By Zachary Brennan

Large scale manufacturing contract revenue in the first quarter of 2013 increased 14% over the same quarter in 2012 as AMRI (Albany Medical Research Inc.) saw an 11% increase in overall revenue. 

Round-up of CMO news

Round-up of CMO news

Contract manufacturing organisations (CMOs) have been busy in the past week, with OsoBio expanding its plant and AMRI adopting a new relationship strategy.